Presbyopia News

Orasis Pharmaceuticals has submitted a new drug application to the FDA for CSF-1, its investigational eye drop candidate for presbyopia, according to a press release.

The options for the treatment of presbyopia continue to expand.

As presbyopia-correcting drops have started to enter the marketplace, many anterior segment surgeons are talking about what our role in prescribing these drops will be.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Yari L. Mitchell, of AcuFocus, provides an update on IOLs for presbyopia correction.

MILAN — At the ESCRS meeting, Roberto Zaldivar, MD, speaks about the latest development of the ICL, the multifocal Viva (STAAR Surgical).

CHICAGO — In this Healio Video Perspective from the AAO meeting, Beeran B. Meghpara, MD, discusses 30-day data from the GEMINI 1 and GEMINI 2 studies.

Since the FDA approval and release of Vuity in late 2021, physicians and patients now have a new option for presbyopia treatment.

NEWPORT BEACH, Calif. — In this Healio Video Perspective, Yari L. Mitchell, chief business development officer at AcuFocus, discusses the panel she moderated on innovations in presbyopia and myopia here at Octane OTS.